EGFR and lung adenocarcinoma: In fact, a retrospective study of 29 patients who received salvage surgery following systemic treatment with first-generation or second-generation EGFR-TKIs for advanced lung adenocarcinoma showed that major pathological response was achieved in only 9 (31.0%) patients, and that pathological complete response (pCR) was not achieved in any patient [2].